Gilead Sciences, Inc. (GILD): Price and Financial Metrics


Gilead Sciences, Inc. (GILD)

Today's Latest Price: $73.51 USD

1.48 (-1.97%)

Updated Apr 9 12:00am

Add GILD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

GILD Stock Summary

  • With a market capitalization of $93,458,567,078, Gilead Sciences Inc has a greater market value than 98.57% of US stocks.
  • Of note is the ratio of Gilead Sciences Inc's sales and general administrative expense to its total operating expenses; merely 17.09% of US stocks have a lower such ratio.
  • The volatility of Gilead Sciences Inc's share price is greater than that of only 1.86% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Gilead Sciences Inc, a group of peers worth examining would be ASML, ABBV, TXN, BMY, and QCOM.
  • Visit GILD's SEC page to see the company's official filings. To visit the company's web site, go to www.gilead.com.
GILD Daily Price Range
GILD 52-Week Price Range

GILD Stock Price Chart More Charts


GILD Price/Volume Stats

Current price $73.51 52-week high $85.97
Prev. close $74.99 52-week low $60.89
Day low $72.95 Volume 12,821,000
Day high $74.60 Avg. volume 19,420,191
50-day MA $71.81 Dividend yield 3.7%
200-day MA $66.83 Market Cap 92.55B

Gilead Sciences, Inc. (GILD) Company Bio


Gilead Sciences is a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.

GILD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$73.51$74.962%

We started the process of determining a valid price forecast for Gilead Sciences Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Gilead Sciences Inc ranked in the 45th percentile in terms of potential gain offered. The most interesting components of our discounted cash flow analysis for Gilead Sciences Inc ended up being:

  • Gilead Sciences Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than merely 0% of US stocks with positive free cash flow.
  • The weighted average cost of capital for the company is 7. This value is greater than just 14.08% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%0%
1%1%
2%2%
3%3%
4%4%
5%5%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as GILD, try ICLR, NHC, REGN, ADMT, and SYNH.


GILD Latest News Stream


Event/TimeNews Detail
Loading, please wait...

GILD Latest Social Stream


Loading social stream, please wait...

View Full GILD Social Stream

GILD Price Returns

1-mo 0.67%
3-mo 14.09%
6-mo 17.03%
1-year 15.08%
3-year 22.97%
5-year -16.77%
YTD 14.18%
2019 7.88%
2018 -9.92%
2017 2.96%
2016 -27.59%
2015 8.63%

GILD Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full GILD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9841 seconds.